Haemonetics Corporation (HAE)

NYSE: HAE · Real-Time Price · USD

63.08

0.06 (0.10%)

At close: May 01, 2025, 3:59 PM

62.99

-0.14%

After-hours: May 01, 2025, 05:05 PM EDT

Dividends

No dividend history available for Haemonetics Corporation.

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Full Definition

Related Stocks

Company	Dividend Yield
Alcon	0.35%
ResMed	0.89%
The Cooper Companies	0.02%
West Pharmaceutical Services	0.39%
Aptar	1.2%
Teleflex Incorporated	0.97%

Dividend Rankings

HAE News

1 day ago · Haemonetics (HAE) Earnings Expected to Grow: Should You Buy? - zacks.com
20 hours ago · 4 MedTech Stocks Poised to Outshine Q1 Earnings Estimates - zacks.com
2 days ago · New Harris Poll findings reveal HAE patients are unsatisfied with current prophylactic treatment options, with over 90% interested in trying new therapies - businesswire.com
3 weeks ago · KalVista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical to Commercialize Sebetralstat for HAE in Japan - businesswire.com
1 month ago · KalVista Pharmaceuticals Announces Early Completion of Enrollment in KONFIDENT-KID Pediatric HAE Trial - businesswire.com
1 month ago · Is it Apt to Retain HAE Stock in Your Portfolio for Now? - zacks.com
2 months ago · Astria Therapeutics: A High-Conviction Bet On HAE - seekingalpha.com
2 months ago · HAE Q3 Earnings In Line, '25 Sales View Cut, Stock Up in Aftermarket - zacks.com
2 months ago · Haemonetics Corporation (HAE) Q3 2025 Earnings Call Transcript - seekingalpha.com
2 months ago · Haemonetics (HAE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - zacks.com